PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 1, 2026Medicina0 citationsOpen Access

Advances in Diagnosis and Treatment of ANCA-Associated Glomerulonephritis

Advances in the Diagnosis, Treatment and Prognosis of ANCA-Associated Glomerulonephritis

View Full Paper

Authors

ACAglaia ChalkiaDPDimitrios Petras

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates improved outcomes in ANCA-associated glomerulonephritis, highlighting the need for early treatment.

Key Points

  • To investigate advancements in diagnosing, treating, and predicting outcomes in ANCA-associated glomerulonephritis.
  • Examined renal manifestations in microscopic polyangiitis and granulomatosis with polyangiitis
  • Outlined two-phase treatment involving glucocorticoids and rituximab or cyclophosphamide
  • Identified novel biomarkers for disease prognosis.
  • Induction therapy led to significantly improved kidney survival rates
  • Use of avacopan reduced corticosteroid complications, enhancing patient safety
  • Novel biomarkers correlated with disease activity and prognosis.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chalkia et al. (2026) studied this question.

synapsesocial.com/papers/6a44aedf5cd2549c8bc43f84https://doi.org/10.3390/medicina62071252
Ask AI
Helpful
Bookmark
Share
View Full Paper